Cardinal Health Inc.
Cardinal Health Announces Q2 FY2025 Results, Raises FY2025 Guidance, and Completes Acquisition of GI Alliance Majority Stake
Summary
Cardinal Health, Inc. reported a 4% decrease in Q2 FY2025 revenue to $55.3 billion, excluding the impact of a large customer contract expiration, with non-GAAP operating earnings increasing by 9% to $635 million. The company raised its fiscal year 2025 non-GAAP EPS guidance to a range of $7.85 to $8.00 and announced the completion of its acquisition of a 73% ownership of GI Alliance. These results will be further discussed during a webcast on January 30, 2025.
Profitelligence Alerts
Get alerts for CAH
Be first to know when Cardinal Health Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Official SEC Documents
Advertisement